Equine anti-thymocyte globulin/Antilymphocyte immunoglobulin (horse)

Specification

• Cat#: THP-0107
• Product Name: Equine anti-thymocyte globulin/Antilymphocyte immunoglobulin (horse)
• Description: Equine anti-thymocyte globulin is composed of purified gamma globulin containing primarily IgG against human thymus lymphocytes. It is formed by inoculating a horse with an antigen (human thymoyctes) which then induces the horse immune system's B-lymphocytes to produce IgG immunoglobulins specific for that antigen. The result is polyclonal IgG that is then purified from the horse's serum to produce a usable product that can be used for immunosuppression.
• Sequences: Not Available
• Species: Horse
• Molecular Weight: Not Available
• Cas No: Not Available
• Formula: Not Available
• Endotoxin Level: <0.001 EU per 1 μg of the peptide by the LAL method
• Biological Activity: 50 mg/1mL

Pharmaceutical Information

• Pharmaceutical Application: Antilymphocyte immunoglobulin (horse)
• Applications: For prevention of renal transplant rejection and for the treatment of aplastic anemia.
• Examples of Clinical Use: Renal transplant rejection and aplastic anemia
• Pharmacodynamics: Not Available
• Mechanism of action: Not Available
• Affected organisms: Not Available